Ovarian Neoplasms
Showing 1 - 25 of 7,150
Experience in Borderline Ovarian Tumors
Not yet recruiting
- Borderline Ovarian Tumor
- (no location specified)
Mar 17, 2023
Shanghai Ovarian Cancer and Family Care Project
Recruiting
- Ovarian Cancer
-
Shanghai, Shanghai, ChinaShanghai first maternity and infant hospital
Oct 31, 2023
Engrailed (EN)-2 in Epithelial Ovarian Neoplasms
Completed
- Ovarian Neoplasms
- Immunohistochemical staining of normal and neoplastic ovarian tissues by anti human Engrailed-2 antibody.
-
Sohag, EgyptSohag faculty of medicine
Sep 25, 2022
Ovarian Cancer Trial in Helsinki (Biomolecular profiling)
Recruiting
- Ovarian Cancer
- Biomolecular profiling
-
Helsinki, FinlandHelsinki University and Helsinki University Hospital
Nov 1, 2023
Total Management of Ovarian Cancer
Not yet recruiting
- Tumor of Female Reproductive System
- Ovarian Cancer
- No intervention
- (no location specified)
Aug 30, 2023
Ovarian Tumors Trial (MRI)
Not yet recruiting
- Ovarian Neoplasms
- MRI
- (no location specified)
Mar 3, 2023
Ovarian Cancer Trial in France (tests to determine HRD status)
Not yet recruiting
- Ovarian Cancer
- tests to determine HRD status
-
Amiens, France
- +3 more
Nov 22, 2023
Epithelial Ovarian Cancer: A Retrospective Study
Recruiting
- Epithelial Ovarian Cancer
- Hematologic features
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiao Tong University Schoo
Oct 16, 2023
Ovarian Cancer Trial in Roma (Blood sample)
Recruiting
- Ovarian Cancer
- Blood sample
-
Roma, ItalyPoliclinico Universitario Agostino Gemelli
Oct 10, 2023
Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)
Not yet recruiting
- Ovarian Cancer Recurrent
- Fluzopril Combined With Apatinib
- (no location specified)
Oct 22, 2023
Metabolic Biomarkers and Their Prognostic Relationship in
Not yet recruiting
- Ovarian Cancer
- No intervention
- (no location specified)
Aug 24, 2023
Doppler Ultrasound and CT Versus Laparoscopy in Assessment of
Recruiting
- Ovarian Cancer
- Laparoscopy
-
Mansoura, Dakahlia, EgyptMansoura University Hospital
Oct 25, 2023
Platinum-resistant Ovarian Cancer
Not yet recruiting
- Ovarian Cancer
- pegylated liposomal doxorubicin
- (no location specified)
Aug 2, 2023
Ovarian Tumors, Sarcopenia Trial in Chambéry (Sarcopenia diagnostic test)
Recruiting
- Ovarian Neoplasms
- Sarcopenia
- Sarcopenia diagnostic test
-
Chambéry, Savoie, FranceCentre Hospitalier Metropole Savoie
Apr 17, 2023
Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)
Not yet recruiting
- Serous Ovarian Cancer
- Advanced Ovarian Cancer
- SC0191
- +2 more
- (no location specified)
Sep 20, 2023
Ovarian Cancer Trial in Roma (Blood samples)
Not yet recruiting
- Ovarian Cancer
- Blood samples
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 3, 2023
Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)
Not yet recruiting
- Ovarian Cancer
- +5 more
- MIRRORS Protocol
- Standard Open Cytoreductive Surgery
- (no location specified)
Jul 17, 2023
Participation Patterns Among Recurrent Ovarian Cancer Patients
Not yet recruiting
- Recurrent Ovarian Cancer
-
San Francisco, CaliforniaPower Life Sciences
Sep 30, 2023
Improved Diagnosis of Ovarian Cancer
Recruiting
- Ovarian Neoplasms
- +6 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
May 1, 2023
Ovarian Tumors, Ovarian Diseases Trial (Adebrelimab, Fuzuloparib)
Not yet recruiting
- Ovarian Neoplasms
- Ovarian Diseases
- (no location specified)
Feb 23, 2023
Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Recruiting
- Ovarian Neoplasms
- +2 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
Mar 9, 2023
Transforming Ovarian Cancer Diagnostic Pathways
Not yet recruiting
- Ovarian Cancer
-
Birmingham, United Kingdom
- +2 more
Nov 10, 2023
Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)
Not yet recruiting
- Ovarian Cancer
- Olaparib tablet
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Nov 1, 2023